Present and Future Therapies of Skin Diseases

Dear Colleagues,

After having come to an accurate diagnosis in a dermatology case, the first question we all face is the inevitable, “What should we use in treatment?”

Although the options are broad (e.g., topicals, phototherapy, surgery, systemic therapy), for many decades, managing cutaneous disorders has been a rigid, “dead water” area where not many changes had been seen. However, in the new millennium, especially in recent years, there have been dramatic changes in the therapeutic armamentarium. New treatments have emerged, and novel therapeutic modalities have been introduced in many areas of skin diseases, which we all must study and apply in our daily practice.

This Special Issue on “Present and Future Therapies of Skin Diseases” aims to present new and available as well as future, promising, not yet used treatments in dermatology. Articles on the management of common or less common, chronic or acute, severe or mild diseases are welcome. Topics of interest include, but are not limited to:

• Acne, rosacea
• Atopic dermatitis
• Bullous skin disorders
• Chronic urticaria
• Hidradentis suppurativa
• Itch/pruritus
• Melanoma
• Pediatric dermatology
• Psoriasis

The issue will review and introduce to the reader the mainstream and the most dynamically progressing therapeutic areas in dermatology; however, the presentation of special treatments for vulnerable populations (e.g., elderly or pediatric dermatology, COVID-19 with cutaneous symptoms) may also be considered for publication. All papers should aim to serve and provide new information to the practicing dermatology community, offering a more profound understanding of skin disease management.

Dr. Gáspár Krisztián József
Dr. Szabó Imre Lőrinc
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.